Avenir Wellness Solutions, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
10-Q: Avenir Wellness Solutions Reports Q3 2024 Results: Revenue Declines Amid Cost-Cutting Measures
Avenir Wellness Solutions experienced a significant decrease in revenue during the third quarter of 2024, alongside reduced operating expenses and a net loss.
OTC.Pink
Avenir Wellness Solutions has filed an amended quarterly report to correct an error in the calculation of weighted average shares outstanding, impacting earnings per share for the first quarter of 2022.
OTC.Pink
Avenir Wellness Solutions, formerly CURE Pharmaceutical Holding Corp., has filed an amended quarterly report to restate its earnings per share for the nine months ended September 30, 2021, due to an error in calculating weighted average shares outstanding.
OTC.Pink
Avenir Wellness Solutions has filed an amended 10-Q report to restate its earnings per share for the six months ended June 30, 2021, due to an error in the calculation of weighted average shares outstanding.
OTC.Pink
10-Q: Avenir Wellness Solutions Reports Q2 2024 Results: Revenue Declines Amid Cost-Cutting Measures
Avenir Wellness Solutions reported a decrease in revenue for the second quarter of 2024, alongside reduced operating expenses and a net loss.
OTC.Pink
Avenir Wellness Solutions experienced a significant decrease in revenue during the first quarter of 2024, alongside a net loss, as detailed in their recent 10-Q filing.